While Medicaid expansion has improved access to medication-assisted treatment for individuals involved in the criminal justice system, the share of such OUD patients receiving MAT still lags behind the general population.
A Phase II clinical trial conducted in London found that in a select group of patients, doses of psilocybin produced comparable antidepressant effects as escitalopram, a commonly prescribed medication for the treatment of depression.
Findings from the latest National Center for Health Statistics data brief released by CDC this month highlight an increase in the co-involvement of opioids in drug overdose deaths that involve cocaine and psychostimulants in recent years, particularly in the Northeast.
Ketamine has been demonstrated to be effective in treating mental health disorders, chronic pain and addiction by causing several developments in key areas of the brain associated with these conditions.
U.S. Rep. David Trone discussed the merger of his Freshmen Working Group on Addiction with the Bipartisan Opioid Task Force on Thursday at the Rx Summit. Rep. Lori Trahan, meanwhile, said she is reintroducing legislation to standardize SUD training for prescribers.